Antiarrhythmic Potential of Anticytokine Therapy in Rheumatoid Arthritis: Tocilizumab Reduces Corrected QT Interval by Controlling Systemic Inflammation

Pietro Enea Lazzerini, Maurizio Acampa, Pier Leopoldo Capecchi, Irene Fineschi, Enrico Selvi, Valentina Moscadelli, Stefania Zimbone, Daniela Gentile, Mauro Galeazzi, Franco Laghi-Pasini
  • Arthritis Care & Research, February 2015, Wiley
  • DOI: 10.1002/acr.22455

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: MD Pietro Enea Lazzerini and Dr Maurizio Acampa